Related stories
Marriott Raises Annual Room Revenue Growth Forecast
M impact | EQUITY | Nov 02, 2026, 12:20 PM UTC
Tower Semiconductor Q3 Net Profit More Than Doubles to $119.89 Million
M impact | EQUITY | Nov 02, 2026, 12:09 PM UTC
Marvell Narrows Fiscal Q3 2027 Revenue Guidance Range to ±2%, Maintains Midpoint
M impact | EQUITY | Nov 02, 2026, 12:08 PM UTC
Marriott worldwide RevPAR increased 6.5%
M impact | EQUITY | Nov 02, 2026, 12:08 PM UTC
Lexeo Reports Sustained Neurological Benefit for LX2006 Through 36 Months
Lexeo says its LX2006 trial showed sustained neurological benefit in Friedreich ataxia through 36 months.
M impact | EQUITY | Nov 02, 2026, 12:07 PM UTC
Vireo Growth to Report Third-Quarter Financial Results
M impact | EQUITY | Nov 02, 2026, 12:07 PM UTC